Here's how to take on the challenge of selecting the right materials for an implantable medical device.

Len Czuba

I don’t think that there is any challenge more confusing to product development teams than selecting materials that can be used for long-term implantable medical devices.

Are there databases where implantable materials are featured? Can we go to our local supplier and ask them to recommend a material that can be used for implant applications? Usually the answer to both questions is “No." There are not databases that offer a variety of implantable materials like produce at a supermarket, nor would they be accurate if they did exist. 

As with most materials used in medical devices, the end use application dictates the selection of the...

January 18th, 2017
0
More on the potential for corporate tax reform and repatriation

Alex Gorsky, Johnson & Johnson chairman and CEO—“Based upon the conversations that we’ve had, the opportunity to go to more of a territorial-based system will result in us being much more competitive, hopefully taking out some of the anomalies that cause us to do inversions, other factors that result in us being less competitive. That could be a very good thing. Secondly, just lowering the rates so that we can be more competitive. Third, a very important issue is, how do we repatriate some of...

January 17th, 2017
0
The potential for corporate tax reform and repatriation

Karen Parkhill, Medtronic CFO—"We would say that the Republican blueprint, as written right now, is a slight benefit for Medtronic if the details remain similar to what is written on the high level. There are puts and takes in the tax reform. The benefit of repatriation would be the largest benefit for us.

On the repatriation side, it is our assumption that there will be an impact on both accumulated foreign earnings and on cash currently overseas. We have...

January 17th, 2017
0
The potential for new HHS leadership

Omar Ishrak, Medtronic chairman and CEO—"Improve outcomes and lower costs—that’s what value-based healthcare is. I know there is overall support for that notion. The journey toward value-based healthcare is not going to change, no matter who the administration is. There is no other alternative. I think there is general agreement around that. The question is, how do you get there? We think that some of the programs that have been put in place by CMS are ones that will probably stay in some form. I think the CJR will almost certainly stay and...

January 17th, 2017
0
The potential for market impact from uncertainty around ACA "repeal and replace"

Omar Ishrak, Medtronic chairman and CEO—“To the degree that we can tell, we haven’t really seen anything dramatic. This thing is pretty steady, the U.S. market is holding. We think that our new product introduction cycles in the U.S. especially have a bigger impact on our growth rates at this stage than the markets themselves. The markets are pretty steady . . .”

Alex Gorsky, Johnson & Johnson chairman and CEO—“We haven’t seen a significant increase in hospital volumes . . . I think...

January 17th, 2017
0

Medical device executives look ahead to the changes expected to come out of Washington, DC this year. Here's how they see issues like the medical device tax, repatriation, and agency leadership impacting their companies.

2017 is set to be a year of upheaval. The Trump administration and the new Congress are expected to usher in legislative changes while unwinding current policies. This of course is likely to mean big changes for the healthcare industry.

One move anticipated by many industry onlookers is a permanent repeal of the medical device excise tax. According to recently...

January 17th, 2017
0

If you’re heading to Anaheim, CA, for the world's largest annual medtech expo and conference February 7–9, 2017, be sure to check out these goings-on at the event.

Jamie Hartford

Next month, medical device professionals from across the country will converge in sunny Southern California to attend Medical Design & Manufacturing (MD&M) West, the world’s largest annual medtech event.

For more than three decades, the MD&M West expo and conference has united the industry’s top innovators with cutting-edge suppliers and forward-thinking influencers to help speed their medical device products to market. This year’s event will bring together more than 20,000 engineers and executives for three days of networking and...

January 13th, 2017
0

Here are five ways to innovate and re-engineer sales and marketing that can help medical device companies become more nimble competitors against low-cost players.

Robert Boyce

The medical device industry is being forced to change, and change fast. The reason: the high cost of sales and marketing. In established medical device companies, sales and marketing accounts for about one third of the cost of a device, about double of what is found in other mature industries.

The business model was built decades ago when the sales rep was the preeminent expert that the surgeon leaned on to learn about the technical and clinical uses of a device. Reps created deep personal relationships with physicians and were by their side in the operating room. At a time when...

January 13th, 2017
0

Johnson & Johnson Medical Devices Companies recently announced the launch of CareAdvantage, its answer to the value-based care environment. A top JNJ executive explains why he thinks the company’s offering has an edge.

Marie Thibault

Johnson & Johnson Medical Devices Companies (JJMDC) is jumping feet first into the value-based care environment with its new CareAdvantage offering. The broad program, announced on January 9, aims to help hospital customers achieve the ultimate goal of value-based care: improving outcomes, increasing patient satisfaction, and reducing the cost of care.

According to ...

January 13th, 2017
0

Here's how middleware’s capabilities can move medical devices from charting to active patient monitoring and intervention.

John Zaleski, PhD, CAP, CPHIMS

Historically, medical device data has been isolated, trapped in silos, each having unique communication protocols, physical connections, update rates, and terminology, but key advances have put medical devices on the precipice of an evolutionary leap from charting and documentation to active patient monitoring and intervention.

Tracked through multivariate, temporally trended information, clinicians can apply historical and real-time data to facilitate real-time clinical decision-making that is based upon changing and evolving trends.

...
January 12th, 2017
0